Abstract No. 255 Single-System Outcomes Using 90-Yittrium Radioembolization as a Primary, Definitive Treatment Approach for Early- to Intermediate-Stage Hepatocellular Carcinoma
JVIR
FEBRUARY 21, 2024
90Yittrium (90Y) radioembolization has emerged as a secondary treatment option for early- to intermediate-stage hepatocellular carcinoma (HCC) in the Barcelona Clinic Liver Cancer (BCLC) Staging and Treatment Algorithm.
Let's personalize your content